Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT78 | Individual Protein | Beta amyloid A4 protein | Homo sapiens | Activity | = | 59.2 | % | 25356913 |
NPT2 | Others | Unspecified | Inhibition | = | 92.1 | % | 22545792 | |
NPT2 | Others | Unspecified | Inhibition | = | 54.9 | % | 12828466 | |
NPT5345 | Individual Protein | Mitogen-activated protein kinase 1 | Rattus norvegicus | Inhibition | = | 50 | % | 17190456 |
NPT2 | Others | Unspecified | Inhibition | = | 18.4 | % | 23252603 | |
NPT5345 | Individual Protein | Mitogen-activated protein kinase 1 | Rattus norvegicus | IC50 | = | 295000 | nM | 23822556 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 100 | PubChem BioAssay data set | ||
NPT1427 | Individual Protein | c-Jun N-terminal kinase 2 | Homo sapiens | Inhibition | = | 82 | % | 16499325 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 100 | 22801644 | ||
NPT78 | Individual Protein | Beta amyloid A4 protein | Homo sapiens | Activity | = | 60.3 | % | 23398362 |
NPT283 | Individual Protein | MAP kinase p38 alpha | Homo sapiens | Inhibition | = | 50 | % | 17722904 |
NPT78 | Individual Protein | Beta amyloid A4 protein | Homo sapiens | Activity | = | 60.1 | % | 25537532 |
NPT283 | Individual Protein | MAP kinase p38 alpha | Homo sapiens | IC50 | = | 252000 | nM | 12502331 |
NPT1427 | Individual Protein | c-Jun N-terminal kinase 2 | Homo sapiens | Inhibition | = | 80 | % | 25798528 |
NPT2 | Others | Unspecified | IC50 | = | 34900 | nM | 18500841 | |
NPT78 | Individual Protein | Beta amyloid A4 protein | Homo sapiens | Activity | = | 60 | % | 18347108 |
NPT1427 | Individual Protein | c-Jun N-terminal kinase 2 | Homo sapiens | IC50 | = | 2500 | nM | 10.1021/np50060a047 |
NPT1427 | Individual Protein | c-Jun N-terminal kinase 2 | Homo sapiens | IC50 | = | 2200 | nM | 12502328 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC271208 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC233224 |
0.9919 | High Similarity | NPC227160 |
0.9919 | High Similarity | NPC82111 |
0.9837 | High Similarity | NPC226862 |
0.9837 | High Similarity | NPC165128 |
0.9837 | High Similarity | NPC158471 |
0.9837 | High Similarity | NPC57119 |
0.9683 | High Similarity | NPC100223 |
0.9683 | High Similarity | NPC158526 |
0.9683 | High Similarity | NPC16830 |
0.9683 | High Similarity | NPC171928 |
0.9683 | High Similarity | NPC33611 |
0.9683 | High Similarity | NPC129687 |
0.9609 | High Similarity | NPC474139 |
0.9609 | High Similarity | NPC189474 |
0.9597 | High Similarity | NPC158737 |
0.9531 | High Similarity | NPC31530 |
0.9531 | High Similarity | NPC47181 |
0.9528 | High Similarity | NPC7744 |
0.9457 | High Similarity | NPC25333 |
0.9457 | High Similarity | NPC49235 |
0.9457 | High Similarity | NPC148893 |
0.9457 | High Similarity | NPC18576 |
0.9453 | High Similarity | NPC266848 |
0.9453 | High Similarity | NPC136750 |
0.9389 | High Similarity | NPC123526 |
0.9389 | High Similarity | NPC193666 |
0.9389 | High Similarity | NPC88640 |
0.938 | High Similarity | NPC170779 |
0.938 | High Similarity | NPC90083 |
0.9375 | High Similarity | NPC65183 |
0.9375 | High Similarity | NPC261812 |
0.9375 | High Similarity | NPC104077 |
0.9375 | High Similarity | NPC259742 |
0.9375 | High Similarity | NPC72046 |
0.9375 | High Similarity | NPC147616 |
0.9375 | High Similarity | NPC219671 |
0.9355 | High Similarity | NPC18449 |
0.9355 | High Similarity | NPC121783 |
0.9355 | High Similarity | NPC34902 |
0.9313 | High Similarity | NPC101807 |
0.9313 | High Similarity | NPC469981 |
0.9308 | High Similarity | NPC135777 |
0.9308 | High Similarity | NPC142547 |
0.9297 | High Similarity | NPC192255 |
0.9268 | High Similarity | NPC126935 |
0.9268 | High Similarity | NPC57268 |
0.9268 | High Similarity | NPC172676 |
0.9268 | High Similarity | NPC301641 |
0.9268 | High Similarity | NPC80241 |
0.9268 | High Similarity | NPC216929 |
0.9268 | High Similarity | NPC65933 |
0.9268 | High Similarity | NPC312713 |
0.9248 | High Similarity | NPC312199 |
0.9242 | High Similarity | NPC113550 |
0.9219 | High Similarity | NPC171550 |
0.9219 | High Similarity | NPC134764 |
0.9173 | High Similarity | NPC46591 |
0.9141 | High Similarity | NPC476748 |
0.9111 | High Similarity | NPC298317 |
0.9111 | High Similarity | NPC255566 |
0.9111 | High Similarity | NPC265154 |
0.9106 | High Similarity | NPC344161 |
0.9104 | High Similarity | NPC471908 |
0.9091 | High Similarity | NPC121651 |
0.9077 | High Similarity | NPC471505 |
0.9062 | High Similarity | NPC222127 |
0.9062 | High Similarity | NPC82862 |
0.9055 | High Similarity | NPC213711 |
0.9055 | High Similarity | NPC40352 |
0.9044 | High Similarity | NPC179521 |
0.9037 | High Similarity | NPC311057 |
0.9037 | High Similarity | NPC474295 |
0.903 | High Similarity | NPC56091 |
0.9023 | High Similarity | NPC185908 |
0.9015 | High Similarity | NPC174191 |
0.8984 | High Similarity | NPC8050 |
0.8984 | High Similarity | NPC473093 |
0.8984 | High Similarity | NPC473092 |
0.8971 | High Similarity | NPC185071 |
0.8971 | High Similarity | NPC12728 |
0.8955 | High Similarity | NPC156376 |
0.8947 | High Similarity | NPC11453 |
0.8931 | High Similarity | NPC106739 |
0.8915 | High Similarity | NPC281864 |
0.8915 | High Similarity | NPC54321 |
0.8915 | High Similarity | NPC328682 |
0.8906 | High Similarity | NPC285725 |
0.8906 | High Similarity | NPC50683 |
0.8906 | High Similarity | NPC206882 |
0.8906 | High Similarity | NPC112571 |
0.8905 | High Similarity | NPC141569 |
0.8905 | High Similarity | NPC477701 |
0.8905 | High Similarity | NPC166884 |
0.8897 | High Similarity | NPC80326 |
0.8897 | High Similarity | NPC302506 |
0.8897 | High Similarity | NPC246947 |
0.8897 | High Similarity | NPC472562 |
0.8889 | High Similarity | NPC177868 |
0.8889 | High Similarity | NPC216434 |
0.8889 | High Similarity | NPC103448 |
0.8881 | High Similarity | NPC166184 |
0.8881 | High Similarity | NPC283949 |
0.8872 | High Similarity | NPC184938 |
0.8872 | High Similarity | NPC150534 |
0.8872 | High Similarity | NPC101624 |
0.8864 | High Similarity | NPC169973 |
0.8864 | High Similarity | NPC196937 |
0.8864 | High Similarity | NPC1474 |
0.8855 | High Similarity | NPC40432 |
0.8855 | High Similarity | NPC161557 |
0.8855 | High Similarity | NPC27843 |
0.8855 | High Similarity | NPC115207 |
0.8855 | High Similarity | NPC228346 |
0.8855 | High Similarity | NPC158079 |
0.8855 | High Similarity | NPC7171 |
0.8841 | High Similarity | NPC205316 |
0.8837 | High Similarity | NPC177167 |
0.8837 | High Similarity | NPC98745 |
0.8832 | High Similarity | NPC477898 |
0.8824 | High Similarity | NPC58137 |
0.8824 | High Similarity | NPC300798 |
0.8806 | High Similarity | NPC143895 |
0.8797 | High Similarity | NPC110958 |
0.8797 | High Similarity | NPC19890 |
0.8788 | High Similarity | NPC181049 |
0.8788 | High Similarity | NPC207400 |
0.8779 | High Similarity | NPC275950 |
0.8777 | High Similarity | NPC3982 |
0.8769 | High Similarity | NPC21867 |
0.8769 | High Similarity | NPC129570 |
0.8769 | High Similarity | NPC45774 |
0.8769 | High Similarity | NPC470084 |
0.8769 | High Similarity | NPC11258 |
0.8769 | High Similarity | NPC184733 |
0.8769 | High Similarity | NPC128208 |
0.8769 | High Similarity | NPC282703 |
0.8768 | High Similarity | NPC84181 |
0.8768 | High Similarity | NPC191158 |
0.8768 | High Similarity | NPC177644 |
0.876 | High Similarity | NPC9891 |
0.876 | High Similarity | NPC186845 |
0.876 | High Similarity | NPC88297 |
0.8759 | High Similarity | NPC287124 |
0.8759 | High Similarity | NPC174522 |
0.875 | High Similarity | NPC226547 |
0.875 | High Similarity | NPC278076 |
0.8722 | High Similarity | NPC205915 |
0.8712 | High Similarity | NPC476345 |
0.8705 | High Similarity | NPC38041 |
0.8705 | High Similarity | NPC469586 |
0.8705 | High Similarity | NPC279298 |
0.8705 | High Similarity | NPC22150 |
0.8705 | High Similarity | NPC180953 |
0.8696 | High Similarity | NPC474808 |
0.8686 | High Similarity | NPC472711 |
0.8682 | High Similarity | NPC17348 |
0.8672 | High Similarity | NPC249788 |
0.8667 | High Similarity | NPC32189 |
0.8647 | High Similarity | NPC97316 |
0.8647 | High Similarity | NPC4940 |
0.8643 | High Similarity | NPC205796 |
0.8643 | High Similarity | NPC276753 |
0.8643 | High Similarity | NPC241846 |
0.8643 | High Similarity | NPC112861 |
0.8643 | High Similarity | NPC93610 |
0.8636 | High Similarity | NPC145305 |
0.8636 | High Similarity | NPC242807 |
0.8636 | High Similarity | NPC187998 |
0.8636 | High Similarity | NPC153739 |
0.8636 | High Similarity | NPC42300 |
0.8636 | High Similarity | NPC92164 |
0.8636 | High Similarity | NPC64201 |
0.8636 | High Similarity | NPC77040 |
0.8636 | High Similarity | NPC257582 |
0.8636 | High Similarity | NPC181079 |
0.8636 | High Similarity | NPC241522 |
0.8636 | High Similarity | NPC173308 |
0.8636 | High Similarity | NPC174495 |
0.8633 | High Similarity | NPC92693 |
0.8633 | High Similarity | NPC218841 |
0.8629 | High Similarity | NPC81067 |
0.8629 | High Similarity | NPC9341 |
0.8623 | High Similarity | NPC210354 |
0.8623 | High Similarity | NPC176586 |
0.8615 | High Similarity | NPC274356 |
0.8603 | High Similarity | NPC14022 |
0.8603 | High Similarity | NPC474039 |
0.8603 | High Similarity | NPC196420 |
0.8593 | High Similarity | NPC99572 |
0.8593 | High Similarity | NPC236522 |
0.8593 | High Similarity | NPC126409 |
0.8571 | High Similarity | NPC18979 |
0.8571 | High Similarity | NPC277804 |
0.8571 | High Similarity | NPC477702 |
0.8561 | High Similarity | NPC470950 |
0.8561 | High Similarity | NPC475875 |
0.8561 | High Similarity | NPC185307 |
0.854 | High Similarity | NPC9068 |
0.8537 | High Similarity | NPC165106 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC271208 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.896 | High Similarity | NPD3705 | Approved |
0.8537 | High Similarity | NPD5283 | Phase 1 |
0.8015 | Intermediate Similarity | NPD3027 | Phase 3 |
0.8 | Intermediate Similarity | NPD1357 | Approved |
0.7947 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7947 | Intermediate Similarity | NPD4965 | Approved |
0.7947 | Intermediate Similarity | NPD4966 | Approved |
0.7931 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD6234 | Discontinued |
0.7748 | Intermediate Similarity | NPD37 | Approved |
0.7671 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.7655 | Intermediate Similarity | NPD6674 | Discontinued |
0.7639 | Intermediate Similarity | NPD1375 | Discontinued |
0.763 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7609 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7576 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7574 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7574 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7533 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD7199 | Phase 2 |
0.75 | Intermediate Similarity | NPD6783 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7228 | Approved |
0.7482 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7465 | Intermediate Similarity | NPD1613 | Approved |
0.7465 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7447 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7447 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7447 | Intermediate Similarity | NPD5109 | Approved |
0.7432 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7421 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD4237 | Approved |
0.7415 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7413 | Intermediate Similarity | NPD3657 | Discovery |
0.7397 | Intermediate Similarity | NPD7266 | Discontinued |
0.7385 | Intermediate Similarity | NPD228 | Approved |
0.7383 | Intermediate Similarity | NPD5058 | Phase 3 |
0.7368 | Intermediate Similarity | NPD4210 | Discontinued |
0.7365 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7365 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD2978 | Approved |
0.7355 | Intermediate Similarity | NPD2977 | Approved |
0.7343 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7343 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7319 | Intermediate Similarity | NPD5327 | Phase 3 |
0.7317 | Intermediate Similarity | NPD7240 | Approved |
0.7305 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7299 | Intermediate Similarity | NPD1091 | Approved |
0.7293 | Intermediate Similarity | NPD7157 | Approved |
0.7287 | Intermediate Similarity | NPD2684 | Approved |
0.7273 | Intermediate Similarity | NPD7028 | Phase 2 |
0.726 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD4108 | Discontinued |
0.726 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD6331 | Phase 2 |
0.7244 | Intermediate Similarity | NPD5563 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7231 | Intermediate Similarity | NPD3022 | Approved |
0.7231 | Intermediate Similarity | NPD3021 | Approved |
0.7222 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7211 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7208 | Intermediate Similarity | NPD6055 | Clinical (unspecified phase) |
0.7206 | Intermediate Similarity | NPD5585 | Approved |
0.7197 | Intermediate Similarity | NPD7843 | Approved |
0.7197 | Intermediate Similarity | NPD5535 | Approved |
0.7194 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD6895 | Approved |
0.7192 | Intermediate Similarity | NPD6896 | Approved |
0.7183 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7172 | Intermediate Similarity | NPD6355 | Discontinued |
0.7172 | Intermediate Similarity | NPD5735 | Approved |
0.7153 | Intermediate Similarity | NPD5125 | Phase 3 |
0.7153 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD5126 | Approved |
0.7153 | Intermediate Similarity | NPD17 | Approved |
0.7152 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7133 | Intermediate Similarity | NPD6658 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD5494 | Approved |
0.7107 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7099 | Intermediate Similarity | NPD5451 | Approved |
0.7095 | Intermediate Similarity | NPD2438 | Suspended |
0.7083 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.708 | Intermediate Similarity | NPD5691 | Approved |
0.7077 | Intermediate Similarity | NPD1358 | Approved |
0.7073 | Intermediate Similarity | NPD3818 | Discontinued |
0.7071 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.707 | Intermediate Similarity | NPD3382 | Approved |
0.707 | Intermediate Similarity | NPD3383 | Approved |
0.707 | Intermediate Similarity | NPD3384 | Approved |
0.7067 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD3060 | Approved |
0.7059 | Intermediate Similarity | NPD7243 | Clinical (unspecified phase) |
0.705 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7047 | Intermediate Similarity | NPD5762 | Approved |
0.7047 | Intermediate Similarity | NPD5763 | Approved |
0.7041 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD6387 | Discontinued |
0.7032 | Intermediate Similarity | NPD1653 | Approved |
0.7027 | Intermediate Similarity | NPD5588 | Approved |
0.7021 | Intermediate Similarity | NPD8651 | Approved |
0.7021 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7014 | Intermediate Similarity | NPD7095 | Approved |
0.7013 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7007 | Intermediate Similarity | NPD2492 | Phase 1 |
0.7007 | Intermediate Similarity | NPD1182 | Approved |
0.7 | Intermediate Similarity | NPD1608 | Approved |
0.7 | Intermediate Similarity | NPD1840 | Phase 2 |
0.7 | Intermediate Similarity | NPD3134 | Approved |
0.6992 | Remote Similarity | NPD1139 | Approved |
0.6992 | Remote Similarity | NPD1137 | Approved |
0.6986 | Remote Similarity | NPD4140 | Approved |
0.6986 | Remote Similarity | NPD1558 | Phase 1 |
0.6982 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6981 | Remote Similarity | NPD6374 | Clinical (unspecified phase) |
0.698 | Remote Similarity | NPD3539 | Phase 1 |
0.6968 | Remote Similarity | NPD5976 | Discontinued |
0.6966 | Remote Similarity | NPD5718 | Phase 2 |
0.6962 | Remote Similarity | NPD7945 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD6111 | Discontinued |
0.6959 | Remote Similarity | NPD4536 | Approved |
0.6959 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD7097 | Phase 1 |
0.6959 | Remote Similarity | NPD4538 | Approved |
0.6957 | Remote Similarity | NPD1651 | Approved |
0.6954 | Remote Similarity | NPD4162 | Approved |
0.695 | Remote Similarity | NPD4359 | Approved |
0.695 | Remote Similarity | NPD3685 | Discontinued |
0.6948 | Remote Similarity | NPD4123 | Phase 3 |
0.694 | Remote Similarity | NPD1138 | Approved |
0.6933 | Remote Similarity | NPD3540 | Phase 1 |
0.6929 | Remote Similarity | NPD1281 | Approved |
0.6912 | Remote Similarity | NPD709 | Approved |
0.6908 | Remote Similarity | NPD4628 | Phase 3 |
0.6906 | Remote Similarity | NPD6516 | Phase 2 |
0.6906 | Remote Similarity | NPD5846 | Approved |
0.6905 | Remote Similarity | NPD7685 | Pre-registration |
0.6903 | Remote Similarity | NPD1940 | Clinical (unspecified phase) |
0.6899 | Remote Similarity | NPD6385 | Approved |
0.6899 | Remote Similarity | NPD6386 | Approved |
0.6894 | Remote Similarity | NPD5604 | Discontinued |
0.6892 | Remote Similarity | NPD6353 | Approved |
0.6887 | Remote Similarity | NPD1372 | Clinical (unspecified phase) |
0.6887 | Remote Similarity | NPD4664 | Clinical (unspecified phase) |
0.6886 | Remote Similarity | NPD7074 | Phase 3 |
0.6871 | Remote Similarity | NPD8127 | Discontinued |
0.6871 | Remote Similarity | NPD2238 | Phase 2 |
0.6863 | Remote Similarity | NPD2677 | Approved |
0.6861 | Remote Similarity | NPD3596 | Phase 2 |
0.6855 | Remote Similarity | NPD1934 | Approved |
0.6849 | Remote Similarity | NPD6798 | Discontinued |
0.6848 | Remote Similarity | NPD4481 | Phase 3 |
0.6846 | Remote Similarity | NPD7119 | Phase 2 |
0.6842 | Remote Similarity | NPD5177 | Phase 3 |
0.6833 | Remote Similarity | NPD7680 | Approved |
0.6826 | Remote Similarity | NPD7054 | Approved |
0.6821 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD3686 | Approved |
0.6815 | Remote Similarity | NPD3687 | Approved |
0.6813 | Remote Similarity | NPD5772 | Approved |
0.6813 | Remote Similarity | NPD8455 | Phase 2 |
0.6813 | Remote Similarity | NPD5773 | Approved |
0.6809 | Remote Similarity | NPD1611 | Approved |
0.6806 | Remote Similarity | NPD4624 | Approved |
0.6806 | Remote Similarity | NPD6584 | Phase 3 |
0.6803 | Remote Similarity | NPD4870 | Approved |
0.6803 | Remote Similarity | NPD6233 | Phase 2 |
0.68 | Remote Similarity | NPD5960 | Phase 3 |
0.6797 | Remote Similarity | NPD3020 | Approved |
0.6795 | Remote Similarity | NPD7526 | Approved |
0.6795 | Remote Similarity | NPD52 | Approved |
0.6795 | Remote Similarity | NPD7527 | Clinical (unspecified phase) |
0.6788 | Remote Similarity | NPD6671 | Approved |
0.6786 | Remote Similarity | NPD2668 | Approved |
0.6786 | Remote Similarity | NPD4626 | Approved |
0.6786 | Remote Similarity | NPD2667 | Approved |
0.6786 | Remote Similarity | NPD7472 | Approved |
0.6783 | Remote Similarity | NPD7258 | Clinical (unspecified phase) |
0.6783 | Remote Similarity | NPD1283 | Approved |
0.6781 | Remote Similarity | NPD2669 | Clinical (unspecified phase) |
0.6779 | Remote Similarity | NPD2653 | Approved |
0.6779 | Remote Similarity | NPD6653 | Approved |
0.6776 | Remote Similarity | NPD2808 | Discontinued |
0.6772 | Remote Similarity | NPD4005 | Discontinued |
0.677 | Remote Similarity | NPD2358 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD2560 | Approved |
0.677 | Remote Similarity | NPD3817 | Phase 2 |
0.677 | Remote Similarity | NPD2563 | Approved |
0.6763 | Remote Similarity | NPD6580 | Approved |
0.6763 | Remote Similarity | NPD6581 | Approved |
0.6763 | Remote Similarity | NPD1548 | Phase 1 |
0.6761 | Remote Similarity | NPD2231 | Phase 2 |
0.6761 | Remote Similarity | NPD2232 | Approved |
0.6761 | Remote Similarity | NPD2230 | Approved |
0.6761 | Remote Similarity | NPD2235 | Phase 2 |
0.6761 | Remote Similarity | NPD2233 | Approved |
0.6757 | Remote Similarity | NPD5837 | Clinical (unspecified phase) |
0.6755 | Remote Similarity | NPD6032 | Approved |
PubChem CID   | 12310041 |
ChEMBL   | CHEMBL2151191 |
ZINC   |
Molecular Weight:   | 340.13 |
ALogP:   | -0.5935 |
MLogP:   | 3.11 |
XLogP:   | 3.822 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 46.15 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 5 |
# Heavy Atoms:   | 25 |